Related Experiment Videos
Time course of carbamazepine self-induction
Journal of Pharmacokinetics and Biopharmaceutics
|February 1, 1979
Summary
Carbamazepine metabolism shows significant self-induction early in treatment, with further induction occurring over weeks. This complex process affects drug elimination rates during repetitive oral dosing.
Area of Science:
- Pharmacokinetics
- Drug Metabolism
- Clinical Pharmacology
Background:
- Carbamazepine is an antiepileptic drug requiring careful therapeutic drug monitoring.
- Understanding carbamazepine's elimination is crucial for optimizing patient dosing regimens.
- Repetitive oral dosing can alter drug metabolism and elimination kinetics.
Purpose of the Study:
- To analyze carbamazepine plasma concentrations during repetitive oral dosing.
- To investigate dose-to-dose changes in the drug's apparent elimination rate constant.
- To characterize the time course and nature of carbamazepine self-induction.
Main Methods:
- Utilized a nonlinear, variable parameter regression program (VARPARM).
- Assumed dose-to-dose variability in the elimination rate constant.
- Analyzed plasma carbamazepine concentrations from repetitive oral dosing studies.
Main Results:
- Significant self-induction of carbamazepine metabolism was observed as early as 1-2 days after initiating multiple-dose therapy.
- Further carbamazepine self-induction was evident after approximately 2 weeks of treatment.
- The time course of carbamazepine self-induction was found to be complex, discontinuous, and prolonged.
Conclusions:
- Carbamazepine exhibits early and prolonged self-induction of its metabolism.
- The elimination of carbamazepine is significantly influenced by self-induction during chronic oral administration.
- These findings highlight the dynamic changes in carbamazepine pharmacokinetics over time.